China SXT Pharmaceuticals, Inc. (SXTC): Price and Financial Metrics
GET POWR RATINGS... FREE!
SXTC Stock Summary
- With a market capitalization of $4,959,850, China SXT Pharmaceuticals Inc has a greater market value than only 0.17% of US stocks.
- With a one year PEG ratio of 0.03, China SXT Pharmaceuticals Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than just 0.38% of US stocks.
- As for revenue growth, note that SXTC's revenue has grown -176.82% over the past 12 months; that beats the revenue growth of only 0.28% of US companies in our set.
- If you're looking for stocks that are quantitatively similar to China SXT Pharmaceuticals Inc, a group of peers worth examining would be WILC, ITP, AKO.B, BVH, and GT.
- Visit SXTC's SEC page to see the company's official filings. To visit the company's web site, go to www.sxtchina.com.
SXTC Valuation Summary
- SXTC's price/sales ratio is 20.6; this is 442.11% higher than that of the median Healthcare stock.
- SXTC's price/sales ratio has moved down 77.5 over the prior 32 months.
- Over the past 32 months, SXTC's price/sales ratio has gone down 77.5.
Below are key valuation metrics over time for SXTC.
SXTC Stock Price Chart Interactive Chart >
SXTC Price/Volume Stats
|Current price||$1.53||52-week high||$28.00|
|Prev. close||$1.63||52-week low||$1.26|
|Day high||$1.65||Avg. volume||295,274|
|50-day MA||$1.76||Dividend yield||N/A|
|200-day MA||$6.06||Market Cap||3.11M|
China SXT Pharmaceuticals, Inc. (SXTC) Company Bio
China Sxt Pharmaceuticals, Inc. engages in the development, manufacture, marketing, sales, research and development of Chinese traditional medicine. It sells Advanced TCMP, Fine TCMP and Regular TCMP products. The company sell its products under "Suxuantang" brand name. The company was founded by Zhou Feng in 2005 and is headquartered in Taizhou, China.
Most Popular Stories View All
SXTC Latest News Stream
|Loading, please wait...|
SXTC Latest Social Stream
View Full SXTC Social Stream
Latest SXTC News From Around the Web
Below are the latest news stories about China SXT Pharmaceuticals Inc that investors may wish to consider to help them evaluate SXTC as an investment opportunity.
Good morning, investor!
Good morning, trader!
Aegis Capital Corp. Acted as Sole Bookrunner on a $4.1 Million Underwritten Public Offering of Ordinary Shares, Inclusive of the Over-Allotment, for China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC).
NEW YORK, NY / ACCESSWIRE /January 20, 2022 / Aegis Capital Corp. acted as Sole Bookrunner on a $4.
China SXT Pharmaceuticals, Inc. Announces Successful Closing of $4.1 Million Follow-on Underwritten Offering of Ordinary Shares and Pre-Funded Warrants With Simultaneous Exercise of the Over-Allotment
TAIZHOU, China, Jan. 20, 2022 (GLOBE NEWSWIRE) -- China SXT Pharmaceuticals, Inc. ("SXTC" or the "Company"), (NASDAQ: SXTC), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces ("TCMPs"), including Advanced TCMPs (Directly-Oral TCMP and After-Soaking-Oral TCMP), fine TCMPs, regular TCMPs, and TCM Homologous Supplements ("TCMHS"), today announced the closing of an underwritten public offering (the “Of
China SXT Pharmaceuticals (SXTC) plunged 55.4% in premarket trade after it priced its earlier announced underwritten public offering of shares and prefunded warrants with gross
SXTC Price Returns
Continue Researching SXTCHere are a few links from around the web to help you further your research on China SXT Pharmaceuticals Inc's stock as an investment opportunity:
China SXT Pharmaceuticals Inc (SXTC) Stock Price | Nasdaq
China SXT Pharmaceuticals Inc (SXTC) Stock Quote, History and News - Yahoo Finance
China SXT Pharmaceuticals Inc (SXTC) Stock Price and Basic Information | MarketWatch